SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 5

Relapsed acute myeloid leukemia presenting with myocardial hypertrophy and constrictive pericardial physiology

Aynur ACIBUCA
Mahmut YERAL
Nazım Emrah KOÇER
Zafer KOÇ
Hakan GÜLLÜ
Pages
287–289
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover,EMR rarely occurs in the heart and there are few cases reportingcardiac relapses in leukemia (2-5).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Extra medullary relapse (EMR) after stem cell transplantationcan be seen up to 20% of acute leukemia patients (1).
📊
Key Findings & Data:Extra medullary relapse (EMR) after stem cell transplantationcan be seen up to 20% of acute leukemia patients (1).
💡
Conclusion & Impact:Moreover,EMR rarely occurs in the heart and there are few cases reportingcardiac relapses in leukemia (2-5).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Extra medullary relapse (EMR) after stem cell transplantationcan be seen up to 20% of acute leukemia patients (1). Moreover,EMR rarely occurs in the heart and there are few cases reportingcardiac relapses in leukemia (2-5).

🔖

Cite This Article

ACIBUCA, A., YERAL, M., KOÇER, N. E., KOÇ, Z., GÜLLÜ, H. (2019). Relapsed acute myeloid leukemia presenting with myocardial hypertrophy and constrictive pericardial physiology. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 5, 287–289. https://ajindex.com/articles/367304

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Clark WB, Strickland SA, Barrett AJ, Savani BN. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica 2010; 95: 860-3
  2. Jung MH, Lee YH, Lee KY, Jung HO, Youn HJ. Leukemic infiltration presenting as myocardial hypertrophy after complete remission of acute myeloid leukemia. Echocardiography 2017; 34: 136-8
  3. Facenda-Lorenzo M, Sánchez-Quintana A, Quijada-Fumero A, Laynez-Carnicero A, Breña-Atienza J, Poncela-Mireles FJ, et al. Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. Case Rep Oncol Med 2016; 2016: 5091021
  4. Chang K, Kim DY, Lee KH, Huh J, Kang JW, Shin DY, et al. An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia. Korean J Intern Med 2017; 32: 753-7
  5. Hori T, Suzuki N, Mizue N, Hatakeyama N, Takamuro M, Tsutsumi H. Relapse of T-cell all after stem cell trans- plant presenting as hypertrophic cardiomyopathy: the value of non-invasive diagnostic imaging in detecting cardiac leukemia. Pediatr Blood Cancer 2006; 46: 108-11
  6. Roberts WC, Bodey GP, Wertlake PT. The heart in acute leukemia: A study of 420 autopsy cases. Am J Cardiol 1968; 21: 388-412
  7. Barbaric D, Holley D, Lau KC, McCowage G. It is ALL in the heart: A patient with acute lymphoblastic leukemia and cardiac infiltration at time of diagnosis. Leuk Lymphoma 2002; 43: 2417-9
  8. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol 2005; 6: 219-28
  9. Makaryus AN, Tung F, Liu W, Mangion J, Kort S. Extensive neoplastic cardiac infiltration in a patient with acute myelogenous leukemia: role of echocardiography. Echocardiography 2003; 20: 539-44
  10. Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 2013; 106: 528-40.